CoChat

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

Open access
Okita, Akira, Takahashi, Shin, Ouchi, Kota, Inoue, Masahiro, Watanabe, Mika, Endo, Mareyuki, Honda, Hiroshi, Yamada, Yasuhide, Ishioka, Chikashi · 2018 · Oncotarget
Cited by 155

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Akira Okita 1, 2 , Shin Takahashi 1, 2 , Kota Ouchi 1, 2 , Masahiro Inoue 3 , Mika Watanabe 4 , Mareyuki Endo 5 , Hiroshi Honda 6 , Yasuhide Yamada 7, 8 and Chikashi Ishioka 1, 2 1 Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai, Japan 2 Department of Medical Oncology, Tohoku University Hospital, Aoba-ku, Sendai, Japan 3 Department of Clinical Oncology, Akita University Graduate School of Medicine, Akita, Japan 4 Department of Pathology, Tohoku University Graduate School of Medicine, Aobaku, Sendai, Japan 5 Department of Pathology, Sendai Kousei Hospital, Aobaku, Sendai, Japan 6 Department of Surgery, Tohoku Rosai Hospital, Aobaku, Sendai, Japan 7 Department of Clinical Oncology, Hamamatsu University School of Medicine, Higashiku, Hamamatsu, Japan 8 Department of Oncology, National Center for Global Health and Medicine, Tokyo, Japan Correspondence to: Chikashi Ishioka, email: chikashi@tohoku.ac.jp Keywords: consensus molecular subtypes; chemotherapeutic efficacy; predictive biomarkers; colorectal cancer; DNA methylation status Received: October 26, 2017 Accepted: February 24, 2018 Published: April 10, 2018 ABSTRACT The consensus molecular subtypes (CMS) classification is one of the most robust colorectal cancer (CRC) classifications based on comprehensive gene expression profiles. This study aimed to clarify whether the CMS is a predictive factor for therapeutic effects of standard chemotherapies for metastatic CRC (mCRC). We retrospectively enrolled 193 patients with mCRCs, and using comprehensive gene expression data, classified them into 4 subtypes: CMS1–CMS4. The associations between the subtypes and treatment outcomes were analyzed. Regarding first-line chemotherapy, irinotecan (IRI)-based chemotherapy was significantly superior to oxaliplatin (OX)-based chemotherapy for progression-free survival (PFS; hazard ratio [HR] = 0.31, 95% confidence interval [CI] 0.13–0.64) and overall survival (OS; HR = 0.45, 95% CI 0.19–0.99) in CMS4. Regarding the anti-epidermal growth factor receptor (anti-EGFR) therapy, CMS1 showed particularly worse PFS (HR = 2.50, 95% CI 1.31–4.39) and OS (HR = 4.23, 95% CI 1.83–9.04), and CMS2 showed particularly good PFS (HR = 0.67, 95% CI 0.44–1.01) and OS (HR = 0.49, 95% CI 0.27–0.87) compared with the other subtypes. The biological characteristics of CMS may influence the efficacy of chemotherapy. CMS might be a new predictive factor for the efficacy of chemotherapy against mCRCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.24617

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 155

Metadata

Authors
Okita, A., Takahashi, S., Ouchi, K., Inoue, M., Watanabe, M., Endo, M., Honda, H., Yamada, Y., & Ishioka, C.
Venue
Oncotarget
Published
2018-04-10
Volume
9
Issue
27
Pages
18698-18711
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2796691218
Cited by
155
References
12
FWCI
7.08
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer. https://app.cochat.ai/papers/10.18632/oncotarget.24617
The paper
Okita, A., Takahashi, S., Ouchi, K., Inoue, M., Watanabe, M., Endo, M., Honda, H., Yamada, Y., & Ishioka, C. (2018). Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer. Oncotarget. https://doi.org/10.18632/oncotarget.24617

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.